8/5, 7:17 PM (Source: TeleTrader)
more TeleTrader news

Nautilus trading halted after Amazon investment report

Trading in shares of Nautilus Biotechnology Inc. was briefly suspended on Thursday due to volatility after CNBC reported that Inc. acquired a $14.7 million stake in the company. The biotechnology firm's stock jumped over 50% at one point before the halt.

Nautilus made its debut on the Nasdaq Global Select Market on June 10, 2021, through a special purpose acquisition company (SPAC) deal with Arya Sciences Acquisition Corp III. Nautilus describes itself as "a company pioneering a single-molecule protein analysis platform for quantifying the proteome."

The company's stock was up 17.49% at 1:14 am ET, selling for $8.79.

Breaking the News / MS